Efficacy News and Research

RSS

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

Abbott has announced that it has received U.S. Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients four years of age and older.

26 Feb 2008

ImClone Systems enrols first patient in clinical trial of IMC-1121B to treat liver cancer

ImClone Systems Incorporated has announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).

26 Feb 2008

Quality of care for inflammatory bowel disease patients can be improved

Inflammatory bowel disease (IBD) is a chronic recurrent gastrointestinal disease.

26 Feb 2008

Technology to defeat bacterial infections shows positive results

The use of natural controls against serious bacterial infection and superbugs is being led by a UK company. Scientists at Biocontrol Ltd have presented at the Bacteriophage 2008 meeting in Hertfordshire a first look at the results of their initial Phase II clinical trial.

25 Feb 2008

XYNTHA approved for teatment of hemophilia A by FDA

Wyeth Pharmaceuticals, a division of Wyeth ( NYSE:WYE) , announced today that it has received approval from the U.S. Food and Drug Administration for XYNTHA(TM) (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free), a recombinant factor VIII product, for patients with hemophilia A for both the control and prevention of bleeding episodes and surgical prophylaxis.

22 Feb 2008

Guidelines for evaluation of psychological side-effects of brain injury

In her PhD, defended at the University of the Basque Country, Maria Luisa de Francisco Maiz provided a clinical-forensic evaluation of brain injuries and also a study on the variables that influence the length of "legal time periods".

21 Feb 2008

Computers are able to diagnose Alzheimer's disease faster and more accurately than experts

According to the Alzheimer's Research Trust, there are over 700,000 people currently living in the UK with dementia, of which Alzheimer's disease, a neurodegenerative disease, is the most common form.

21 Feb 2008

Comparison of venlafaxine and SSRIs in the treatment of depression

There are numerous antidepressant medications currently on the market, but sadly, many patients still experience the debilitating symptoms of depression even with treatment.

21 Feb 2008

US advisory committee recommends approval of Rotarix

The US Advisory Committee on Vaccines and Related Biological Products issued a positive recommendation today on the use of rotavirus vaccines, potentially bringing greater protection to children in the US from this common and sometimes fatal cause of severe diarrhea.

21 Feb 2008

A new age-related macular degeneration discovery

Scientists have won a major battle in the fight against age-related macular degeneration, or AMD, a blinding eye disease that affects millions of people.

21 Feb 2008

Doctors in the United States say yes to marijuana

Doctors in the United States have given their endorsement for marijuana to be used for medical purposes.

17 Feb 2008

New non-invasive imaging method for diagnosing osteoarthritis

Researchers at New York University and Tel Aviv University have developed a non-invasive imaging method that can be used to diagnose and monitor a number of diseases, including osteoarthritis and inter-vertebral disc degeneration, in their early stages.

12 Feb 2008

Alpha-linolenic acid good for dry eye syndrome

Research conducted by Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service Director and Harvard Medical School Professor Reza Dana, M.D., M. Sc., MPH, and colleagues at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.

12 Feb 2008

Benefit of removal of the ovaries differs between women with BRCA1 and BRCA2 mutations

The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations.

12 Feb 2008

$1-year results of bronchial thermoplasty in refractory asthma$

1-year results of bronchial thermoplasty in refractory asthma

Asthmatx, Inc. has announced the publication of data from the Research in Severe Asthma (RISA) Trial of bronchial thermoplasty in the American Journal of Respiratory and Critical Care Medicine (AJRCCM, 2007; 176:1185-1191).

12 Feb 2008

Amantadine and rimantadine for influenza A in children and the elderly

The antiviral drug amantadine can prevent some cases of influenza in children, and the related medication rimantadine can reduce fever in youngsters who have the flu, according to a new review of evidence.

8 Feb 2008

Novel drug shows promise in limiting heart attack damage

A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.

8 Feb 2008

Review of psychosocial quit-smoking interventions for patients with coronary heart disease

Psychosocial interventions like counseling, telephone support and self-help materials can assist heart disease patients who are trying to give up cigarettes, but the most successful cessation treatments last a month or more, according to a new review of studies.

8 Feb 2008

Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells

Researchers are identifying innovative therapeutics for sickle cell anemia that focus on specific factors in the disease's progression, such as the important role of hydration of the red blood cells.

7 Feb 2008

Half of patients undergoing cerebrovascular stent placement do not respond well to clopidogrel

A study by researchers at Rush University Medical Center, published in the February issue of the American Journal of Neuroradiology, finds that half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel.

7 Feb 2008

Efficacy News and Research

Abbott receives approval for HUMIRA (Adalimumab) for polyarticular juvenile idiopathic arthritis

ImClone Systems enrols first patient in clinical trial of IMC-1121B to treat liver cancer

Quality of care for inflammatory bowel disease patients can be improved

Technology to defeat bacterial infections shows positive results

XYNTHA approved for teatment of hemophilia A by FDA

Guidelines for evaluation of psychological side-effects of brain injury

Computers are able to diagnose Alzheimer's disease faster and more accurately than experts

Comparison of venlafaxine and SSRIs in the treatment of depression

US advisory committee recommends approval of Rotarix

A new age-related macular degeneration discovery

Doctors in the United States say yes to marijuana

New non-invasive imaging method for diagnosing osteoarthritis

Alpha-linolenic acid good for dry eye syndrome

Benefit of removal of the ovaries differs between women with BRCA1 and BRCA2 mutations

1-year results of bronchial thermoplasty in refractory asthma

Amantadine and rimantadine for influenza A in children and the elderly

Novel drug shows promise in limiting heart attack damage

Review of psychosocial quit-smoking interventions for patients with coronary heart disease

Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells

Half of patients undergoing cerebrovascular stent placement do not respond well to clopidogrel

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News